FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890892753> ?p ?o ?g. }

• W2890892753 endingPage "188" @default.
• W2890892753 startingPage "177" @default.
• W2890892753 abstract "Abstract Vigabatrin is an antiepileptic drug indicated as monotherapy in infantile spasms. However, the pharmacokinetic profile of this compound in infants and young children is still poorly understood, as is the minimal effective dose, critical information given the risk of exposure‐related retinal toxicity with vigabatrin. A reasonable approach to determining this minimal dose would be to identify the lowest dose providing a low risk of exposure overlap with the 36‐mg/kg dose, which is the highest dose associated with an increased risk for treatment failure, based on randomized dose‐ranging data. A population pharmacokinetic model was consequently developed from 28 children (aged 0.4‐5.7 years) for the active S(+)‐enantiomer, using Monolix software. In parallel, a population model was developed from published adult data and scaled to children using theoretical allometry and maturation of the renal function. A one‐compartment model with zero‐order absorption and first‐order elimination described the pediatric data. Mean population estimates (percentage interindividual variability) for the apparent clearance, apparent distribution volume, and absorption duration were 2.36 L/h (24.5%), 17 L (38%), and 0.682 hours, respectively. Apparent clearance and apparent distribution volume were related to body weight by empirical allometric equations. Monte Carlo simulations evidenced that a daily dose of 80 mg/kg should minimize exposure overlap with the 36‐mg/kg dose. Similar results were obtained for the adult model scaled to children. Consequently, a minimal effective dose of 80 mg/kg/day could be considered for patients with infantile spasms." @default.
• W2890892753 created "2018-09-27" @default.
• W2890892753 creator A5008350546 @default.
• W2890892753 creator A5030954067 @default.
• W2890892753 creator A5040559085 @default.
• W2890892753 creator A5044996495 @default.
• W2890892753 creator A5045654612 @default.
• W2890892753 creator A5046418848 @default.
• W2890892753 creator A5084454925 @default.
• W2890892753 creator A5085763160 @default.
• W2890892753 creator A5091149760 @default.
• W2890892753 date "2018-09-07" @default.
• W2890892753 modified "2023-09-30" @default.
• W2890892753 title "Proposition of a Minimal Effective Dose of Vigabatrin for the Treatment of Infantile Spasms Using Pediatric and Adult Pharmacokinetic Data" @default.
• W2890892753 cites W1607402462 @default.
• W2890892753 cites W1948601338 @default.
• W2890892753 cites W1960255425 @default.
• W2890892753 cites W1968787421 @default.
• W2890892753 cites W1990837904 @default.
• W2890892753 cites W1991287426 @default.
• W2890892753 cites W1997190808 @default.
• W2890892753 cites W1998186620 @default.
• W2890892753 cites W2000997080 @default.
• W2890892753 cites W2004427268 @default.
• W2890892753 cites W2014032013 @default.
• W2890892753 cites W2014222625 @default.
• W2890892753 cites W2020365240 @default.
• W2890892753 cites W2031080927 @default.
• W2890892753 cites W2037122149 @default.
• W2890892753 cites W2037604208 @default.
• W2890892753 cites W2039848681 @default.
• W2890892753 cites W2045617136 @default.
• W2890892753 cites W2045790097 @default.
• W2890892753 cites W2046975941 @default.
• W2890892753 cites W2049197928 @default.
• W2890892753 cites W2055924385 @default.
• W2890892753 cites W2060406365 @default.
• W2890892753 cites W2083563713 @default.
• W2890892753 cites W2083699676 @default.
• W2890892753 cites W2088996598 @default.
• W2890892753 cites W2094883317 @default.
• W2890892753 cites W2095185628 @default.
• W2890892753 cites W2095431927 @default.
• W2890892753 cites W2114390763 @default.
• W2890892753 cites W2120416054 @default.
• W2890892753 cites W2125508519 @default.
• W2890892753 cites W2152930906 @default.
• W2890892753 cites W2171386011 @default.
• W2890892753 cites W2218896197 @default.
• W2890892753 cites W2317475716 @default.
• W2890892753 cites W2552835369 @default.
• W2890892753 cites W2766396408 @default.
• W2890892753 doi "https://doi.org/10.1002/jcph.1309" @default.
• W2890892753 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30192381" @default.
• W2890892753 hasPublicationYear "2018" @default.
• W2890892753 type Work @default.
• W2890892753 sameAs 2890892753 @default.
• W2890892753 citedByCount "7" @default.
• W2890892753 countsByYear W28908927532019 @default.
• W2890892753 countsByYear W28908927532020 @default.
• W2890892753 countsByYear W28908927532021 @default.
• W2890892753 countsByYear W28908927532022 @default.
• W2890892753 countsByYear W28908927532023 @default.
• W2890892753 crossrefType "journal-article" @default.
• W2890892753 hasAuthorship W2890892753A5008350546 @default.
• W2890892753 hasAuthorship W2890892753A5030954067 @default.
• W2890892753 hasAuthorship W2890892753A5040559085 @default.
• W2890892753 hasAuthorship W2890892753A5044996495 @default.
• W2890892753 hasAuthorship W2890892753A5045654612 @default.
• W2890892753 hasAuthorship W2890892753A5046418848 @default.
• W2890892753 hasAuthorship W2890892753A5084454925 @default.
• W2890892753 hasAuthorship W2890892753A5085763160 @default.
• W2890892753 hasAuthorship W2890892753A5091149760 @default.
• W2890892753 hasConcept C112705442 @default.
• W2890892753 hasConcept C118552586 @default.
• W2890892753 hasConcept C126322002 @default.
• W2890892753 hasConcept C139254425 @default.
• W2890892753 hasConcept C2775858608 @default.
• W2890892753 hasConcept C2776239304 @default.
• W2890892753 hasConcept C2778186239 @default.
• W2890892753 hasConcept C2780837902 @default.
• W2890892753 hasConcept C2908647359 @default.
• W2890892753 hasConcept C29730261 @default.
• W2890892753 hasConcept C71924100 @default.
• W2890892753 hasConcept C98274493 @default.
• W2890892753 hasConcept C99454951 @default.
• W2890892753 hasConceptScore W2890892753C112705442 @default.
• W2890892753 hasConceptScore W2890892753C118552586 @default.
• W2890892753 hasConceptScore W2890892753C126322002 @default.
• W2890892753 hasConceptScore W2890892753C139254425 @default.
• W2890892753 hasConceptScore W2890892753C2775858608 @default.
• W2890892753 hasConceptScore W2890892753C2776239304 @default.
• W2890892753 hasConceptScore W2890892753C2778186239 @default.
• W2890892753 hasConceptScore W2890892753C2780837902 @default.
• W2890892753 hasConceptScore W2890892753C2908647359 @default.
• W2890892753 hasConceptScore W2890892753C29730261 @default.
• W2890892753 hasConceptScore W2890892753C71924100 @default.
• W2890892753 hasConceptScore W2890892753C98274493 @default.

• next